AstraZeneca PLC (LON: AZN)
London
· Delayed Price · Currency is GBP · Price in GBX
10,474
+412 (4.09%)
Nov 22, 2024, 7:04 PM BST
AstraZeneca Revenue
AstraZeneca had revenue of $13.57B USD in the quarter ending September 30, 2024, with 18.04% growth. This brings the company's revenue in the last twelve months to $51.21B, up 13.81% year-over-year. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.
Revenue (ttm)
$51.21B
Revenue Growth
+13.81%
P/S Ratio
4.25
Revenue / Employee
$569.59K
Employees
89,900
Market Cap
162.38B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | 24.38B | 2.29B | 10.38% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GSK plc | 31.31B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.46B |
ConvaTec Group PLC | 1.74B |
Hikma Pharmaceuticals PLC | 2.39B |
Oxford Nanopore Technologies plc | 167.75M |
Animalcare Group plc | 76.10M |
AstraZeneca News
- 23 hours ago - Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement - Benzinga
- 1 day ago - Lost Money on AstraZeneca PLC (AZN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - Accesswire
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN - Accesswire
- 1 day ago - An Investigation Has Commenced on Behalf of AstraZeneca PLC Shareholders. Contact Levi & Korsinsky to Discuss Your AZN Losses - Accesswire
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN - Accesswire
- 1 day ago - AstraZeneca (AZN) and Amgen (AMGN) Submit New Asthma Drug Application - GuruFocus
- 2 days ago - AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns - Benzinga
- 2 days ago - AstraZeneca PLC (AZN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire